TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Star Therapeutics Stock

Star Therapeutics Stock

www.star-therapeutics.com/Healthcare / BioTech & PharmaFounded: 2018

Star Therapeutics, founded in 2018, is a biotechnology company that aims to look for gaps that exist in the fields of hematology and immunology. The goal is to create life-changing antibody therapies for people who lack options for diseases that do not currently have viable treatments. Star Therapeutics looks for ways to apply the treatments to a variety of diseases and also manages a portfolio of companies. Star Therapeutics is headquartered in San Francisco, California.

Buy or sell Star Therapeutics stockLearn more about Star Therapeutics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Star Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Star Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Star Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Star Therapeutics investors also invested in these private companies

Ra Capital Management
Qatar Investment Authority
New Leaf Venture Partners
Redmile Group
Westlake Village BioPartners
Cormorant Asset Management
Sofinnova Investments
Soleus Capital
OrbiMed
Catalio Capital Management
Agent Capital
NYBC Ventures

Team

Management Team

Kathy Dong
Chief Operating Officer
Sandip Panicker Ph.D
Chief Scientific Officer
Jeremy Boucher
Vice President & Head of Finance
Adam Rosenthal Ph.D
Founder, Chief Executive Officer, & President
Gary Patou MD
Chief Medical Officer

Board Members

Carl Gordon Ph.D
OrbiMed
Nancy Stagliano Ph.D
New Leaf Venture
Vijay Lathi
New Leaf Venture

Frequently Asked Questions About Star Therapeutics’ Stock

plusminus
Can you buy Star Therapeutics’ stock?
Star Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Star Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Star Therapeutics’ stock?
Yes, you can sell stock of a private company like Star Therapeutics. Forge can help you sell your Star Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Star Therapeutics’ stock price?
Star Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Star Therapeutics’ private market stock price with Forge Data.
plusminus
What is Star Therapeutics’ stock ticker symbol?
Star Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Star Therapeutics in the BioTech & Pharma sector

Egenesis

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$387.57MM

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Prime Medicine

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.23B

ADARx Pharmaceuticals

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

Pendulum Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM

Cytonics

Sector
Healthcare / BioTech & Pharma
 
 

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

News Highlights

FierceBiotech 09/05/2023
Investors shower Star Therapeutics with $90M for constellation of biotechs, antibody therapies
Investors have showered Star Therapeutics with $90 million to grow its portfolio companies and develop new antibody drugs for diseases with high unmet need. Sofinnova Investments led the oversubscribed series C round and was joined by new investors Qatar Investment Authority, Catalio Capital Management, Agent Capital, Soleus Capital and NYBC Ventures alongside all seven existing investors. The new funds nearly double the $100 million Star had already raised since its founding in late 2018.

Trending Companies

Frequently Asked Questions

Updated on: Apr 27, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.